|
C15ORF41 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.156400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.806600E-01 |
| Normal-vs-Stage2 |
7.583400E-01 |
| Normal-vs-Stage3 |
7.989900E-02 |
| Normal-vs-Stage4 |
7.671600E-02 |
| Stage1-vs-Stage2 |
6.334000E-01 |
| Stage1-vs-Stage3 |
5.794200E-02 |
| Stage1-vs-Stage4 |
6.768200E-02 |
| Stage2-vs-Stage3 |
2.654800E-01 |
| Stage2-vs-Stage4 |
6.301900E-02 |
| Stage3-vs-Stage4 |
2.864200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.824000E-01 |
| Normal-vs-AfricanAmerican |
4.675200E-01 |
| Normal-vs-Asian |
1.475640E-01 |
| Caucasian-vs-AfricanAmerican |
7.745600E-01 |
| Caucasian-vs-Asian |
1.611580E-01 |
| AfricanAmerican-vs-Asian |
2.559200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.907200E-01 |
| Normal-vs-Female |
2.216300E-03 |
| Male-vs-Female |
4.592300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.032400E-01 |
| Normal-vs-Extreme_Weight |
4.223000E-01 |
| Normal-vs-Obese |
5.274800E-01 |
| Normal-vs-Extreme_Obese |
5.906000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.379800E-02 |
| Normal_Weight-vs-Obese |
5.111400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.677200E-01 |
| Extreme_Weight-vs-Obese |
2.122800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.607800E-01 |
| Obese-vs-Extreme_Obese |
4.314000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.239700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.061200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.129000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.786400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.197900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.407800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.189690E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.663800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.871370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.424000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.560000E-01 |
| Normal-VS-Type2 PRCC |
8.243200E-01 |
| Normal-VS-KIRP CIMP |
2.519300E-03 |
| Normal-VS-Unclassified PRCC |
1.432620E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.392400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.337900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.123800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.95819999946079E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.677230E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.817000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.361400E-01 |
| Normal-vs-N1 |
1.857780E-02 |
| Normal-vs-N2 |
4.506000E-01 |
| N0-vs-N1 |
5.880800E-03 |
| N0-vs-N2 |
1.305390E-01 |
| N1-vs-N2 |
9.248600E-01 |
|
|
